U.S. Tuberculosis (TB) Diagnostics Market by Type (Culture-based Diagnostics, Sputum Smear Microscopy, Rapid Molecular Diagnostics, and Others), by End-user (Diagnostics Laboratories and Hospitals), by United States (Northeast, Southeast, Midwest, Southwest, West) Forecast 2024-2032
The U.S. Tuberculosis (TB) Diagnostics Market size was valued at USD 516 USD Million in 2023 and is projected to reach USD 735.80 USD Million by 2032, exhibiting a CAGR of 5.2 % during the forecast period.TB diagnostics involves the technology and method used to determine Mycobacterium tuberculosis presence. Mycobacterium tuberculosis bacteria cause TB and TB diagnostics are considered for early treatment and prevention of TB. The characteristics of the diagnostics are precision, speed, affordability, and scalability. The diagnostic methods of tuberculosis range from traditional ones like sputum smear microscopy to novel methods like Deoxyribonucleic acid amplification tests (NAATs), Chest X-rays, and molecular tests like GeneXpert MTB/RIF. The TB diagnostics have been adopted across clinical settings to disease surveillance programs, helping in prompt case identification, drug sensitivity testing, and treatment regimens tracking. Technologies like AI and POCT are really changing the bar of TB diagnostics by not only speeding up the process but also performing much more accurately compared to the previously used methods and making the tests available to a much wider group of people.
Type:
End-user:
Aspects | Details |
---|---|
Study Period | 2018-2032 |
Base Year | 2023 |
Estimated Year | 2024 |
Forecast Period | 2024-2032 |
Historical Period | 2018-2023 |
Growth Rate | CAGR of % from 2018-2032 |
Segmentation |
|
Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014
Craig Francis
Business Development Head
+44 1223 92 666
sales@advancemarketanalytics.com
get latest updates and offers.